Affordable Access

Brabykinin B1 Receptor Antagonism Is Beneficial in Renal Ischemia-Reperfusion Injury

Public Library of Science
Publication Date


Previously we have demonstrated that bradykinin B1 receptor deficient mice (B1KO) were protected against renal ischemia and reperfusion injury (IRI). Here, we aimed to analyze the effect of B1 antagonism on renal IRI and to study whether B1R knockout or antagonism could modulate the renal expression of pro and anti-inflammatory molecules. To this end, mice were subjected to 45 minutes ischemia and reperfused at 4, 24, 48 and 120 hours. Wild-type mice were treated intra-peritoneally with antagonists of either B1 (R-954, 200 mg/kg) or B2 receptor (HOE140, 200 mg/kg) 30 minutes prior to ischemia. Blood samples were collected to ascertain serum creatinine level, and kidneys were harvested for gene transcript analyses by real-time PCR. Herein, B1R antagonism ( R-954) was able to decrease serum creatinine levels, whereas B2R antagonism had no effect. The protection seen under B1R deletion or antagonism was associated with an increased expression of GATA-3, IL-4 and IL-10 and a decreased T-bet and IL-1b transcription. Moreover, treatment with R-954 resulted in lower MCP-1, and higher HO-1 expression. Our results demonstrated that bradykinin B1R antagonism is beneficial in renal IRI.

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times

More articles like this

Bradykinin B1 and B2 receptors both have protectiv...

on Proceedings of the National Ac... May 01, 2007

Influence of bradykinin B1 and B2 receptors in the...

on International immunopharmacolo... Dec 20, 2006

The effect of antagonism of adenosine A1 receptor...

on Journal of Surgical Research May 01, 2007

The Role of Cysteinyl-LT1Receptor (CysLT1R) in Ren...

on Transplantation Proceedings Jan 01, 2009
More articles like this..